Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0JZU stock hub

LON/0JZU has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0JZUis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

64.9B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0JZU

In the news

Latest news · LON/0JZU

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.9

P25 12.9P50 16.9P75 23.5

Trailing P/E18

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC106.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0JZU market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

223

Groups with data

Currency

USD

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	45,000
Employees Change	-6,000%
Employees Change Percent	-11.76
Enterprise value	$69.3B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US58155Q1031
Last refreshed	2026-05-10
Market cap	$64.9B
Price	$745
Price currency	USD
Rev Per Employee	6,943,626.28x
Sector	Healthcare
Sic	5122
Symbol	lon/0JZU
Website	https://www.mckesson.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.55%
EV Earnings	19.22x
EV/EBIT	15.33x
EV/EBITDA	12.73x
EV/FCF	16.01x
EV/Sales	0.23x
FCF yield	6.67%
Forward P/E	16.9x
P/B ratio	-102.81x
P/E ratio	18.01x
P/S ratio	0.21x
PE Ratio10 Y	60.64x
PE Ratio3 Y	23.06x
PE Ratio5 Y	24.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.53%
EBITDA Margin	1.71%
FCF margin	1.42%
Gross margin	3.6%
Gross Profit	$11B
Gross Profit Growth	13.31%
Gross Profit Growth Q	24.13%
Gross Profit Growth3 Y	5.91%
Gross Profit Growth5 Y	3.95%
Net Income	$3.6B
Net Income Growth	44.52%
Net Income Growth Q	33.49%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth3 Y	10.18%
Pretax Margin	1.54%
Profit Margin	1.18%
Profit Per Employee	$81,961
Profitable Years	5
ROA	4.89
Roa5y	4.39
ROCE	40.27
ROIC	106.9
Roic5y	294.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	3.84%
Cagr3y	27.67%
Cagr5y	31.61%
Div CAGR3	10.95%
Div CAGR5	13.42%
EPS Growth	49.22
EPS Growth Q	37.03
EPS Growth Quarters	3
EPS Growth Years	2
EPS Growth3 Y	15.32
FCF Growth	3.08%
FCF Growth Q	-54.86%
FCF Growth3 Y	6.24%
FCF Growth5 Y	6.93%
OCF Growth	1.15%
OCF Growth Q	-55.85%
OCF Growth10 Y	5.3%
OCF Growth3 Y	6.06%
OCF Growth5 Y	6.27%
Revenue Growth	12.36x
Revenue Growth Q	6.03x
Revenue Growth Quarters	23x
Revenue Growth Years	13x
Revenue Growth3 Y	13.39x
Revenue Growth5 Y	11.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$5.12
Assets	$62.3B
Cash	$3B
Current Assets	$42B
Current Liabilities	$49.2B
Debt	$6.5B
Debt EBITDA	$1.16
Debt FCF	$1.51
Equity	$-631.6M
Interest Coverage	24.95
Liabilities	$63B
Long Term Assets	$20.4B
Long Term Liabilities	$13.8B
Net Cash	$-3.5B
Net Cash By Market Cap	$-5.41
Net Debt EBITDA	$0.67
Net Debt FCF	$0.81
Tangible Book Value	$-13.3B
Tangible Book Value Per Share	$-111
WACC	5.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.85
Inventory Turnover	16.48
Net Working Capital	$-9.3B
Quick ratio	0.48
Working Capital	$-7.4B
Working Capital Turnover	$-38.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.12%
Dividend Growth	10.47%
Dividend Growth Years	9%
Dividend per share	$2.37
Dividend Years	10
Dividend Yield	0.32%
Ex Div Date	2026-03-02
Last Dividend	$0.61
Payout Frequency	Quarterly
Payout Ratio	8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	3.84%
200-day SMA	812.6
3Y total return	108.12%
50-day SMA	877
50-day SMA vs 200-day SMA	50over200
5Y total return	294.82%
All Time High	1,017
All Time High Change	-26.77%
All Time High Date	2026-03-04
All Time Low	108.3
All Time Low Change	587.35%
All Time Low Date	2018-12-24
ATR	35.75
Beta	0.36
Ch YTD	-9.72
High	772
High52	1,017
High52 Date	2026-03-04
High52ch	-26.77%
Low	736
Low52	637.3
Low52 Date	2025-08-12
Low52ch	16.85%
Ma50ch	-15.09%
Price vs 200-day SMA	-8.36%
RSI	20.12
RSI Monthly	53.09
RSI Weekly	36.27
Sharpe ratio	0.15x
Sortino ratio	0.46
Total Return	3.44%
Tr YTD	-9.65
Tr1m	-12.77%
Tr1w	-8.36%
Tr3m	-20.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$4.7B
Operating Income Growth	25.39
Operating Income Growth Q	66.62
Operating Income Growth3 Y	12.62
Operating Income Growth5 Y	14.18
Operating margin	1.53

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	120,041,849%
Net Borrowing	574,341,462
Shares Insiders	0.03%
Shares Institutions	92.32%
Shares Qo Q	-0.81%
Shares Yo Y	-3.12%
Short Ratio	3.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$4.3B
Average Volume	3,220.65x
Bv Per Share	-13.71
CAPEX	$-330.2M
Ch1m	-12.77
Ch1w	-8.36
Ch1y	3.43
Ch3m	-20.54
Ch3y	105.2
Ch5y	283.9
Ch6m	-12.14
Change	0.36%
Change From Open	-0.97
Close	742
Days Gap	1.34
Depreciation Amortization	534,731,706
Dollar Volume	173,510.4
Earnings Date	2026-05-07
EBIT	$4.7B
EBITDA	$5.2B
EPS	$29.07
F Score	6
FCF	$4.3B
FCF EV Yield	6.25x
Financing CF	-3,507,079,455
Fiscal Year End	March
Founded	1,833
Goodwill	8,300,444,424
Income Tax	$834.6M
Investing CF	-2,599,070,760
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	$421
Lynch Upside	-43.45
Ma150	850.1
Ma150ch	-12.4%
Ma20	822.6
Ma20ch	-9.47%
Net CF	-1,429,791,840
Next Earnings Date	2026-08-05
Open	752
P FCF Ratio	14.99
P OCF Ratio	13.93
Payment Date	2026-04-01
Position In Range	24.12
Ppne	3,466,587,164
Price Date	2026-05-08
Price EBITDA	$12.44
Relative Volume	0.07x
Revenue	305,519,556,150x
Tax By Revenue	0.27x
Tax Rate	17.77%
Tr6m	-11.99%
Volume	233
Z Score	6.08

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0JZU dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$2.37 annual per share

Payout ratio

+8.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+13.4%

9 consecutive years of growth

Total shareholder yield

+3.4%

Next ex-dividend date: 2026-03-02

Performance

LON/0JZU stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0JZU?

Insider, institutional, and short-interest positioning.

Institutional ownership

+92.3%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0JZU momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

20.1

Below 30: short-term oversold

Price vs 200-day MA

-8.4%

50/200-day relationship not available

Beta (5Y)

0.35

Less volatile than the market

Sharpe ratio

0.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0JZU

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0JZU stock rating?

lon/0JZU is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0JZU analysis?

The full report lives at /stocks/lon/0JZU/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0JZU?

The latest report frames lon/0JZU around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0JZU page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.